Magnolia Capital Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$719K Sell
3,253
-239
-7% -$58.5K 0.14% 172
2025
Q4
$885K Sell
3,492
-96
-3% -$24.1K 0.19% 130
2025
Q3
$888K Buy
3,588
+41
+1% +$9.81K 0.23% 117
2025
Q2
$852K Sell
3,547
-34
-0.9% -$7.92K 0.21% 118
2025
Q1
$812K Buy
3,581
+378
+12% +$83.1K 0.22% 113
2024
Q4
$658K Buy
3,203
+717
+29% +$157K 0.17% 135
2024
Q3
$603K Buy
2,486
+6
+0.2% +$1.4K 0.3% 85
2024
Q2
$545K Buy
+2,480
New +$539K 0.3% 80
2023
Q3
Sell
-2,536
Closed -$571K 129
2023
Q2
$571K Hold
2,536
0.29% 78
2023
Q1
$485K Buy
2,536
+133
+6% +$25.7K 0.25% 96
2022
Q4
$444K Buy
2,403
+35
+1% +$6.15K 0.3% 87
2022
Q3
$394K Hold
2,368
0.33% 81
2022
Q2
$488K Buy
+2,368
New +$534K 0.44% 73

Other funds holding STE

Magnolia Capital Advisors's STE Position: Q1 2026 in Review

Magnolia Capital Advisors reduced its Steris (STE) stake by 6.8% in Q1 2026, selling an estimated $58.5K and leaving 3,253 shares worth $719K. The position accounts for 0.14% of the portfolio, ranked #172.

Magnolia Capital Advisors first reported a position in STE in Q2 2022 and has held it in 13 quarters since. The position peaked at $888K in Q3 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Magnolia Capital Advisors held 3,253 shares of Steris worth $719K as of Q1 2026.
  • Magnolia Capital Advisors sold 239 Steris shares in Q1 2026, an estimated $58.5K.
  • Steris made up 0.14% of Magnolia Capital Advisors's portfolio in Q1 2026, its #172 holding.
  • Magnolia Capital Advisors first reported a position in Steris in Q2 2022 and has held it in 13 quarters since.
  • Magnolia Capital Advisors's Steris position peaked at $888K in Q3 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.